Incidence of Clinical and Histopathological Types of Malignant Melanomas and their Sites in Patients in the Žilina Region, Districts Považská Bystrica, Púchov and Ilava in 1997 - 1999
Authors:
E. Minariková 1; J. Péč 1; Ľ. Lauko 2; Z. Frličková 1; V. Strmeňová 3; Z. Belejová 4; M. Minárik 5
Authors‘ workplace:
Klinika dermatovenerológie Martinskej fakultnej nemocnice a Jesseniovej lekárskej fakulty Univerzity Komenského, Martin, prednosta doc. MUDr. Juraj Péč, CSc. 2Ústav patologickej anatómie Martinskej fakultnej nemocnice a Jesseniovej lekárskej fakulty Unive
1
Published in:
Čes-slov Derm, , 2001, No. 3, p. 122-125
Category:
Overview
Malignant melanoma is an aggressive skin tumour the incidence of which is rising worldwide. The authors draw attention to the rising incidence in the Žilina region and districts of Ilava, Považská Bystrica and Púchov, based on data for 1997 - 1999.The authors diagnosed during the period from 1997 - 1999 136 new cases of malignant melanoma. Malignant melanomas were diagnosed in 67 women, mean age 54 years, and in 69 men mean age 58 years. The most frequently diagnosed histopathological type was LMM (44 %), followed by SSM (28 %) and the most frequent localization in men (62 %) and women (37 %) was the trunk.In the conclusion the authors evaluate the rising incidence of malignant melanoma in northern Slovakia in 1999 by more than 100 % as compared with 1997.
Key words:
melanoma malignum - clinical and histopathological types - localization in men and women - incidence of basic types of melanoma malignum - incidence
Labels
Dermatology & STDs Paediatric dermatology & STDsArticle was published in
Czech-Slovak Dermatology
2001 Issue 3
Most read in this issue
- Erythema Annulare Centrifugum - Superficial and Deep Form
- Modern Imaging Methods in Dermatology
- Dramatic Contact Allergic and Toxic Reaction after Cremor Refrigerans (ung. leniens)
- Detection of Some Factors Indicating Possible Autoimmunity (Antibodies against Melanocytes, Thyroglobulin, Thyroid Peroxidase, Stomach Parietal Cell, Microsomes) in Patients Suffering from Vitiligo